NEW YORK (GenomeWeb News) - Enzo Biochem today said that a federal court issued a ruling supporting the company's claims that "hundreds" of products marketed by certain companies infringe eight of Enzo's patents.
 
The ruling allows Enzo to pursue patent-infringement claims against Affymetrix, Roche, Amersham, PerkinElmer, Sigma Aldrich, Orchid Biosciences and Molecular Probes. It also enables Enzo to claim that the defendants breached their contractual obligations to Enzo.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.